RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic
L Tian, T Qiang, C Liang, X Ren, M Jia, J Zhang… - European journal of …, 2021 - Elsevier
The widespread nature of several viruses is greatly credited to their rapidly altering RNA
genomes that enable the infection to persist despite challenges presented by host cells …
genomes that enable the infection to persist despite challenges presented by host cells …
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
LP Jordheim, D Durantel, F Zoulim… - Nature reviews Drug …, 2013 - nature.com
Nucleoside analogues have been in clinical use for almost 50 years and have become
cornerstones of treatment for patients with cancer or viral infections. The approval of several …
cornerstones of treatment for patients with cancer or viral infections. The approval of several …
Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C
EJ Gane, CA Stedman, RH Hyland… - … England Journal of …, 2013 - Mass Medical Soc
Background The standard treatment for hepatitis C virus (HCV) infection is interferon, which
is administered subcutaneously and can have troublesome side effects. We evaluated …
is administered subcutaneously and can have troublesome side effects. We evaluated …
Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus …
E Lawitz, FF Poordad, PS Pang, RH Hyland, X Ding… - The Lancet, 2014 - thelancet.com
Background Interferon-based treatment is not suitable for many patients with hepatitis C
virus (HCV) infection because of contraindications such as psychiatric illness, and a high …
virus (HCV) infection because of contraindications such as psychiatric illness, and a high …
Noninvasive methods to assess liver disease in patients with hepatitis B or C
L Castera - Gastroenterology, 2012 - Elsevier
The prognosis and management of patients with chronic viral hepatitis B and C depend on
the amount and progression of liver fibrosis and the risk for cirrhosis. Liver biopsy …
the amount and progression of liver fibrosis and the risk for cirrhosis. Liver biopsy …
Current and future therapies for hepatitis C virus infection
Current and Future Therapies for Hepatitis C Virus Infection | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search …
Skip to main content The New England Journal of Medicine homepage Advanced Search …
Chronic hepatitis C infection
HR Rosen - New England Journal of Medicine, 2011 - Mass Medical Soc
Chronic Hepatitis C Infection | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …
Direct‐acting antivirals for chronic hepatitis C
JC Jakobsen, EE Nielsen, J Feinberg… - Cochrane database …, 2017 - cochranelibrary.com
Background Millions of people worldwide suffer from hepatitis C, which can lead to severe
liver disease, liver cancer, and death. Direct‐acting antivirals (DAAs), eg sofosbuvir, are …
liver disease, liver cancer, and death. Direct‐acting antivirals (DAAs), eg sofosbuvir, are …
Preliminary study of two antiviral agents for hepatitis C genotype 1
AS Lok, DF Gardiner, E Lawitz… - … England Journal of …, 2012 - Mass Medical Soc
Background Patients with chronic hepatitis C virus (HCV) infection who have not had a
response to therapy with peginterferon and ribavirin may benefit from the addition of multiple …
response to therapy with peginterferon and ribavirin may benefit from the addition of multiple …
APASL consensus statements and recommendation on treatment of hepatitis C
M Omata, T Kanda, L Wei, ML Yu, WL Chuang… - Hepatology …, 2016 - Springer
Abstract The Asian-Pacific Association for the Study of the Liver (APASL) convened an
international working party on the “APASL consensus statements and recommendation on …
international working party on the “APASL consensus statements and recommendation on …